A direct correlation between high levels of LRP/LR expression and tumor aggressiveness has been noted in numerous cancers, including, fibrosarcoma[23], breast[24], cervical[25], colon[26], lung[27], prostate[28], oesophageal[29], liver[30], gastric[31] and ovarian[32] cancer. Here, RPSA is linked to cancer.